Anderson Bruce V MD is categorized under Pathological Laboratories in Orlando, FL and active since 2004.
Anderson Bruce V MD was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Bruce Anderson at the company’s single location by writing to 601 East Rollins St, Orlando, Florida FL 32803 or by phoning (407) 303-1932. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Anderson Bruce V MD |
| Contact Person: | Bruce Anderson |
| Address: | 601 East Rollins St, Orlando, Florida 32803 |
| Phone Number: | (407) 303-1932 |
| Website Address: | flhosplab.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 6211110 |
| Share This Business: |
Anderson Bruce V MD was started in 2004 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Bruce Anderson for inquiries that concern Anderson Bruce V MD by calling the company number (407) 303-1932, as your correspondence is most welcome. Additionally, the physical location of the single location of Anderson Bruce V MD can be found at the coordinates 28.57315,-81.36936 as well as the street address 601 East Rollins St in Orlando, Florida 32803.
For its online presence, you may visit Anderson Bruce V MD’s website at flhosplab.com and engage with its social media outlets through on Twitter and on Facebook.